CD20 (Obinutuzumab) Recombinant Human Monoclonal Antibody (GA101), Functional Grade, Leinco Technologies™

Human Recombinant Monoclonal Antibody

Supplier:  Leinco Technologies Inc LT906100MG

Catalog No. 50-254-4116

Description

Specificity: Obinutuzumab (GA101) activity is directed against human CD20. Endotoxin Level: <1.0 EU/mg as determined by the LAL method. Purity: ≥98% monomer by analytical SEC and >95% by SDS Page. Preparation: Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. Storage: Functional grade biosimilar antibodies may be stored sterile as received at 2-8C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80C. Avoid Repeated Freeze Thaw Cycles.

CD20 (Obinutuzumab) Recombinant Monoclonal antibody specifically detects CD20 (Obinutuzumab) in Cynomolgus Monkey, Human, Rhesus Monkey samples. It is validated for ELISA, Flow Cytometry, Functional Assay, Western Blot

Specifications

• Antigen: CD20 (Obinutuzumab)
• Classification: Recombinant Monoclonal
• Concentration: ≥5.0 mg/mL
• Formulation: PBS with no preservative; pH 7.2-7.4
• Host Species: Human
• Purification Method: Protein A/G
• Regulatory Status: RUO
• Target Species: Cynomolgus Monkey, Human, Rhesus Monkey
• Product Type: Antibody
• Isotype: IgG1 κ

• Applications: ELISA, Flow Cytometry, Functional Assay, Western Blot
• Clone: GA101
• Conjugate: Functional Grade
• Gene Alias: afutuzumab; Gazyva; Gazyvaro; RG7159; RO5072759
• Immunogen: Human lymphoblastoid cell line SB
• Quantity: 100 mg
• Primary or Secondary: Primary
• Content And Storage: 4°C short term, -80°C long term
• Form: Liquid